Literature DB >> 20187236

Sleep disturbances in Parkinson's disease.

Matthew Menza1, Roseanne DeFronzo Dobkin, Humberto Marin, Karina Bienfait.   

Abstract

Sleep disturbances are very common in patients with PD and are associated with a variety of negative outcomes. The evaluation of sleep disturbances in these patients is complex, as sleep may be affected by a host of primary sleep disorders, other primary medical or psychiatric conditions, reactions to medications, aging or the neuropathophysiology of PD itself. In this article, we review the evaluation of the common disturbances of sleep seen in PD. This includes the primary sleep disorders, the interaction of depression and insomnia, the impact that medications for PD have on sleep, as well as the role of factors such as nocturia, pain, dystonia, akinesia, difficulty turning in bed, and vivid dreaming. The treatment of sleep disturbances in PD is largely unstudied but recommendations based on clinical experience in PD and research studies in other geriatric populations can be made. Important principles include, diagnosis, treating the specific sleep disorder or co-occurring disorder, and control of the motor aspects of PD.

Entities:  

Mesh:

Year:  2010        PMID: 20187236      PMCID: PMC2840057          DOI: 10.1002/mds.22788

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  38 in total

Review 1.  Sleep attacks--facts and fiction: a critical review.

Authors:  Carl Nikolaus Homann; Karoline Wenzel; Klaudia Suppan; Gerd Ivanic; Richard Crevenna; Edwin Ott
Journal:  Adv Neurol       Date:  2003

Review 2.  Sleep in Parkinson's disease.

Authors:  A D Lowe
Journal:  J Psychosom Res       Date:  1998-06       Impact factor: 3.006

Review 3.  Parkinson's disease and sleep.

Authors:  Diego Garcia-Borreguero; Oscar Larrosa; Mauricio Bravo
Journal:  Sleep Med Rev       Date:  2003-04       Impact factor: 11.609

4.  Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson's disease.

Authors:  Charles H Adler; John N Caviness; Joseph G Hentz; Marlene Lind; Judy Tiede
Journal:  Mov Disord       Date:  2003-03       Impact factor: 10.338

5.  Benzodiazepines and zolpidem for chronic insomnia: a meta-analysis of treatment efficacy.

Authors:  P D Nowell; S Mazumdar; D J Buysse; M A Dew; C F Reynolds; D J Kupfer
Journal:  JAMA       Date:  1997 Dec 24-31       Impact factor: 56.272

6.  Dream phenomena induced by chronic levodopa therapy.

Authors:  B Sharf; C Moskovitz; M D Lupton; H L Klawans
Journal:  J Neural Transm       Date:  1978       Impact factor: 3.575

7.  Health-related quality of life and sleep disorders in Parkinson's disease.

Authors:  T Scaravilli; E Gasparoli; F Rinaldi; G Polesello; F Bracco
Journal:  Neurol Sci       Date:  2003-10       Impact factor: 3.307

8.  Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism.

Authors:  B F Boeve; M H Silber; J E Parisi; D W Dickson; T J Ferman; E E Benarroch; A M Schmeichel; G E Smith; R C Petersen; J E Ahlskog; J Y Matsumoto; D S Knopman; C H Schenck; M W Mahowald
Journal:  Neurology       Date:  2003-07-08       Impact factor: 9.910

9.  Diphenhydramine in insomniac family practice patients: a double-blind study.

Authors:  K Rickels; R J Morris; H Newman; H Rosenfeld; H Schiller; R Weinstock
Journal:  J Clin Pharmacol       Date:  1983 May-Jun       Impact factor: 3.126

10.  Nocturnal sleep disturbances and daytime dysfunction in patients with Parkinson's disease and in their caregivers.

Authors:  P K Pal; K Thennarasu; J Fleming; M Schulzer; T Brown; S M Calne
Journal:  Parkinsonism Relat Disord       Date:  2004-03       Impact factor: 4.891

View more
  42 in total

Review 1.  The Therapeutic Potential of Exercise to Improve Mood, Cognition, and Sleep in Parkinson's Disease.

Authors:  Gretchen O Reynolds; Michael W Otto; Terry D Ellis; Alice Cronin-Golomb
Journal:  Mov Disord       Date:  2015-12-30       Impact factor: 10.338

2.  Clinical correlates of periodic limb movements in sleep in Parkinson's disease.

Authors:  Naima Covassin; Ariel B Neikrug; Lianqi Liu; Jody Corey-Bloom; Jose S Loredo; Barton W Palmer; Jeanne Maglione; Sonia Ancoli-Israel
Journal:  J Neurol Sci       Date:  2012-01-25       Impact factor: 3.181

3.  Cross-cultural adaptation and psychometric properties of the SCOPA-Sleep-German version.

Authors:  Simone Goebel; Elisabeth Steinmann; Bernd Leplow; H Maximilian Mehdorn
Journal:  Neurol Sci       Date:  2018-04-14       Impact factor: 3.307

4.  The Gender-Biased Effects of Intranasal MPTP Administration on Anhedonic- and Depressive-Like Behaviors in C57BL/6 Mice: the Role of Neurotrophic Factors.

Authors:  Marissa Giovanna Schamne; Josiel Mileno Mack; Morgana Moretti; Filipe Carvalho Matheus; Roger Walz; Laurence Lanfumey; Rui Daniel Prediger
Journal:  Neurotox Res       Date:  2018-05-28       Impact factor: 3.911

Review 5.  Pathological basal ganglia activity in movement disorders.

Authors:  T Wichmann; J O Dostrovsky
Journal:  Neuroscience       Date:  2011-06-22       Impact factor: 3.590

6.  A disruption mechanism of the molecular clock in a MPTP mouse model of Parkinson's disease.

Authors:  Akane Hayashi; Naoya Matsunaga; Hiroyuki Okazaki; Keisuke Kakimoto; Yoshinori Kimura; Hiroki Azuma; Eriko Ikeda; Takeshi Shiba; Mayumi Yamato; Ken-Ichi Yamada; Satoru Koyanagi; Shigehiro Ohdo
Journal:  Neuromolecular Med       Date:  2013-01-05       Impact factor: 3.843

Review 7.  Circadian dysfunction may be a key component of the non-motor symptoms of Parkinson's disease: insights from a transgenic mouse model.

Authors:  L David Willison; Takashi Kudo; Dawn H Loh; Dika Kuljis; Christopher S Colwell
Journal:  Exp Neurol       Date:  2013-01-24       Impact factor: 5.330

8.  Validity and Reliability of SCOPA Sleep Scale Turkish Version in Parkinson's Disease.

Authors:  Neşe Sönmez Kongur; Zeynep Tosun; Serhat Özkan; Nilda Turgut; Aysun Ünal
Journal:  Noro Psikiyatr Ars       Date:  2022-01-31       Impact factor: 1.339

Review 9.  Parkinson disease: an update.

Authors:  Steven J Frucht
Journal:  Neurologist       Date:  2004-07       Impact factor: 1.398

10.  Sleep Dysfunction in Parkinson's Disease.

Authors:  Vinoth Kanna Selvaraj; Bhanu Keshavamurthy
Journal:  J Clin Diagn Res       Date:  2016-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.